August 27, 2024 07:41 AM EDT
Financing
Startups

RA Cap­i­tal and For­bion set up new au­toim­mune biotech with bis­pe­cif­ic from Ko­re­an start­up

Kyle LaHucik

Senior Reporter

An­oth­er au­toim­mune biotech emerged on Tues­day morn­ing with a $100 mil­lion Se­ries A.

Nav­i­ga­tor Med­i­cines launched with a li­cense to a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

FDA ap­proves sub­cu­ta­neous Ocre­vus, broad­en­ing ac­cess to Roche and Genen­tech block­buster

Doug Williams re­turns with a ‘FIT’ bet on CAR-Ts; Bio­gen ap­points Mene Pan­ga­los to board

Cor­rect­ed: Roche’s Tecen­triq scores first US ap­proval for sub­cu­ta­neous PD-L1

Au­rinia re­struc­tures board, bring­ing in Kevin Tang and keep­ing CEO

Neu­ro­crine culls Phase 2 neu­ropsych med af­ter fail­ing to val­i­date ear­li­er da­ta

Post-Hoc: Big promis­es built Mod­er­na. They might al­so be its un­do­ing

A service from the Financial Times